A patient who recently underwent percutaneous coronary intervention (PCI) is exhibiting signs of acute heart failure, including pulmonary congestion and elevated BNP levels. As a nurse, what is the most important initial intervention to address this complication?

C) Administer IV furosemide to reduce pulmonary congestion

A) Administer supplemental oxygen to maintain oxygen saturation

B) Initiate IV morphine to reduce preload and anxiety

C) Administer IV furosemide to reduce pulmonary congestion

D) Encourage the patient to ambulate to improve circulation

A patient who recently underwent PCI for a STEMI is now exhibiting signs of pulmonary congestion and acute heart failure. Intravenous furosemide has been initiated. Which nursing intervention is most important to monitor the patient's response to diuretic therapy?

A) Measure the patient's urine output hourly.

B) Increase the patient's oral fluid intake to promote hydration.

C) Encourage deep breathing exercises to improve oxygenation.

D) Monitor the patient's blood glucose levels regularly.

A patient on diuretic therapy for fluid overload presents with increased urine output, mild confusion, and respiratory acidosis. What is the most appropriate nursing intervention to address the patient's respiratory status?

C) Initiate non-invasive positive pressure ventilation (NIPPV) to enhance ventilation and oxygenation.

A) Discontinue diuretic therapy immediately to prevent further respiratory distress.

B) Administer supplemental oxygen at a higher flow rate to improve oxygen saturation.

C) Initiate non-invasive positive pressure ventilation (NIPPV) to enhance ventilation and oxygenation.

D) Increase the frequency of neurological assessments to monitor for changes in mental status.

A patient receiving furosemide for fluid overload is experiencing respiratory acidosis and mild confusion. Non-invasive positive pressure ventilation (NIPPV) has been initiated. Which nursing action is the priority to address the patient's current condition?

C) Adjust the NIPPV settings to improve ventilation and oxygenation.

A) Increase the rate of diuretic infusion to enhance fluid removal.

B) Monitor the patient's neurological status for any changes.

C) Adjust the NIPPV settings to improve ventilation and oxygenation.

D) Administer supplemental potassium to prevent hypokalemia.

A patient receiving non-invasive positive pressure ventilation (NIPPV) for respiratory distress shows improvement in oxygenation but continues to have intermittent disorientation. The patient's recent lab results show hypokalemia and hypomagnesemia. Which nursing intervention is a priority to address these findings?

B) Administer prescribed potassium and magnesium supplements.

A) Increase the rate of NIPPV to improve oxygen delivery.

B) Administer prescribed potassium and magnesium supplements.

C) Encourage the patient to perform incentive spirometry every hour.

D) Monitor the patient's blood pressure closely for signs of hypotension.

A patient receiving non-invasive positive pressure ventilation (NIPPV) shows improvement in respiratory status, but remains intermittently disoriented. Laboratory results indicate hypokalemia and hypomagnesemia. Which intervention should the nurse prioritize to address the patient's current condition?

A) Administer prescribed potassium and magnesium supplements.

B) Increase the pressure settings on the NIPPV device.

C) Provide a high-protein diet to improve mental clarity.

D) Encourage deep breathing exercises to enhance oxygenation.

A patient with a recent STEMI has an LVEF of 40% and rising troponin levels. The clinical team is considering introducing beta-blocker therapy. Which nursing intervention is most appropriate to prioritize before initiating beta-blocker therapy?

A) Monitor for signs of bradycardia and hypotension.

B) Assess the patient's urine output for signs of renal impairment.

C) Evaluate the patient's diet for sodium intake.

D) Measure the patient's weight daily to monitor for fluid retention.

A patient with a recent STEMI and a left ventricular ejection fraction (LVEF) of 40% is being monitored for potential heart failure progression. The patient's troponin levels have increased, and telemetry shows occasional PVCs. Which nursing intervention is the most appropriate to prioritize given this clinical scenario?

D) Prepare for the potential initiation or titration of a beta-blocker therapy.

A) Encourage the patient to ambulate to improve cardiac conditioning.

B) Administer diuretics to manage potential fluid overload.

C) Notify the healthcare provider about the need for an increase in dietary potassium intake.

D) Prepare for the potential initiation or titration of a beta-blocker therapy.

A patient with a recent myocardial infarction is showing signs of early heart failure, including mild shortness of breath, fatigue, and peripheral edema. The interdisciplinary team has adjusted the patient's treatment plan to include an increased dose of furosemide and initiation of low-dose beta-blocker therapy. Which nursing intervention should be prioritized to monitor the effectiveness of these changes in the patient's care?

A) Monitor daily weight and assess for changes in peripheral edema.

B) Encourage increased oral fluid intake to prevent dehydration.

C) Administer supplemental oxygen to maintain oxygen saturation above 95%.

D) Perform hourly blood pressure checks to monitor for hypotension.

A patient with a recent myocardial infarction presents with mild shortness of breath, fatigue, faint crackles at lung bases, and mild peripheral edema. After diagnostic testing, it is determined the patient is experiencing early heart failure. Which nursing intervention is most appropriate to prioritize at this time?

B) Position the patient in high Fowler's position to facilitate breathing.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Position the patient in high Fowler's position to facilitate breathing.

C) Educate the patient on the importance of a high-protein diet to improve energy levels.

D) Administer prescribed potassium supplements to prevent hypokalemia.

STEMI - Nursing Case Study

Pathophysiology

• Primary mechanism: STEMI (ST-Elevation Myocardial Infarction) occurs when a coronary artery is completely blocked by a thrombus (blood clot) that forms due to the rupture of an atherosclerotic plaque. This blockage halts blood flow, causing ischemia and subsequent necrosis of the heart muscle supplied by the affected artery.

• Secondary mechanism: The lack of oxygen (ischemia) leads to cellular injury and death, resulting in the release of cardiac biomarkers like troponins into the bloodstream. This process triggers an inflammatory response, further exacerbating myocardial damage.

• Key complication: If not promptly treated, STEMI can lead to heart failure, arrhythmias, or even cardiac arrest due to the significant loss of functional myocardial tissue. Rapid restoration of blood flow through reperfusion therapy is critical to minimizing damage.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia

• Current medications: Metformin 500 mg BID, Lisinopril 10 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, diaphoresis, nausea, lightheadedness

• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 24 breaths/min, temperature 37.8°C, oxygen saturation 92% on room air

Section 1

New Complications:

Following the initial management of the STEMI, which included administration of aspirin and nitroglycerin, the patient was quickly transferred to the cardiac catheterization lab for percutaneous coronary intervention (PCI). The procedure successfully revascularized the occluded left anterior descending artery. However, within a few hours post-PCI, the patient began exhibiting signs of potential complications. His respiratory status worsened, with increasing shortness of breath and a drop in oxygen saturation to 88% on room air despite supplemental oxygen. Auscultation of the lungs revealed bilateral crackles, suggesting pulmonary congestion.

The developing scenario indicated the possibility of acute heart failure secondary to the myocardial insult. This was corroborated by a repeat assessment of vital signs, which showed a heart rate of 120 bpm and a blood pressure of 150/95 mmHg, indicating a compensatory mechanism to maintain cardiac output. A chest X-ray confirmed the presence of pulmonary edema, and laboratory tests revealed an elevated brain natriuretic peptide (BNP) level. These findings pointed to the heart's inability to effectively pump blood, leading to fluid accumulation in the lungs.

The clinical team initiated diuretic therapy with intravenous furosemide to manage the pulmonary congestion and closely monitored electrolytes and renal function. This intervention aimed to alleviate symptoms and prevent further deterioration of cardiac function. The nursing staff was tasked with ongoing monitoring of the patient's respiratory status, fluid balance, and vital signs to assess the effectiveness of the treatment and detect any further complications. The patient's response to the diuretic therapy over the next few hours would be crucial in determining the next steps in his care, including potential adjustments to his medication regimen or additional cardiac support.

Section 2

As the diuretic therapy commenced, the nursing team diligently monitored the patient's response to the intervention. Over the next few hours, the patient's urine output increased significantly, suggesting effective diuresis with a total output of 600 mL in the first two hours. This was a positive sign, indicating that the furosemide was helping to reduce the fluid overload. However, despite this promising response, the patient's respiratory distress persisted, with oxygen saturation fluctuating between 88% and 90% on supplemental oxygen. His heart rate remained elevated at 115 bpm, and his blood pressure slightly decreased to 140/90 mmHg, which, while still elevated, suggested some reduction in the sympathetic response.

A repeat chest X-ray revealed persistent pulmonary congestion, albeit with slight improvement compared to the initial post-PCI imaging. Concurrently, the patient began to experience mild confusion and disorientation, raising concerns about his neurological status. A stat arterial blood gas (ABG) analysis was performed, revealing a pH of 7.32, PaCO2 of 48 mmHg, PaO2 of 60 mmHg, and HCO3- of 24 mEq/L, indicative of respiratory acidosis. This finding highlighted the need to address not only the pulmonary congestion but also the potential for hypercapnic respiratory failure.

Given these developments, the clinical team decided to escalate the patient's care. A non-invasive positive pressure ventilation (NIPPV) was initiated to improve oxygenation and reduce the work of breathing. The patient's electrolyte levels were closely monitored, with special attention to potassium and magnesium, given the risk of imbalance due to diuretic therapy. The patient's situation necessitated a re-evaluation of his medication regimen, considering the possibility of adding afterload-reducing agents to further assist the heart's pumping ability. Continuous monitoring and reassessment would be key to tailoring interventions and preventing further complications in his recovery journey.

Section 3

As the nursing team continued to monitor the patient following the initiation of non-invasive positive pressure ventilation (NIPPV), there was a noticeable improvement in his respiratory status. Within the first hour of NIPPV, the patient's oxygen saturation increased to a more stable range of 92% to 94%, and his respiratory rate decreased from 28 to 22 breaths per minute, indicating a reduction in respiratory distress. Despite this positive trend in oxygenation, the patient’s mental status remained a concern. Although his confusion slightly improved, he still exhibited intermittent disorientation, prompting further neurological assessment.

A comprehensive metabolic panel was obtained to assess the patient’s electrolyte status, revealing a potassium level of 3.2 mEq/L and a magnesium level of 1.6 mg/dL, both of which were below normal limits. These findings suggested that the diuretic therapy was contributing to electrolyte imbalances, necessitating prompt replacement therapy. Potassium and magnesium supplements were administered, and their levels were closely monitored to prevent arrhythmias, especially given the patient's elevated heart rate and recent myocardial infarction.

Meanwhile, the patient's blood pressure continued to exhibit a downward trend, now measuring 130/85 mmHg, indicating the need to carefully balance fluid status and cardiac output. The clinical team opted to start a low dose of an ACE inhibitor to help reduce afterload and further support cardiac function. This decision was made to enhance the heart's efficiency in pumping against the systemic circulation, thereby alleviating some strain on the myocardium. As the patient's condition evolved, the interdisciplinary team remained vigilant, poised to adjust therapeutic strategies based on continuous assessment and emerging clinical data.

Section 4

As the interdisciplinary team continued to monitor the patient, new diagnostic results brought to light another layer of complexity in his clinical picture. An echocardiogram was performed to evaluate cardiac function more thoroughly. The results revealed a left ventricular ejection fraction (LVEF) of 40%, indicating moderately reduced systolic function. This finding was consistent with the patient's recent STEMI and suggested that the myocardial damage had a significant impact on the heart's pumping ability. The diminished ejection fraction raised concerns about the potential for heart failure progression, necessitating vigilant monitoring for signs of fluid overload or worsening cardiac output.

Simultaneously, a repeat troponin test showed an upward trend, with levels rising from 1.5 ng/mL to 2.8 ng/mL over the past 12 hours. This elevation suggested ongoing myocardial injury, possibly from continued ischemia or infarct extension. The clinical team, aware of the potential for arrhythmias due to both electrolyte imbalances and myocardial strain, continued to prioritize rhythm monitoring. The patient’s telemetry showed occasional premature ventricular contractions (PVCs), prompting the team to adjust electrolyte replacement strategies to maintain optimal potassium and magnesium levels more aggressively.

In response to these developments, the team decided to consult cardiology for potential adjustments in the patient's medical management, including considering the introduction or titration of beta-blocker therapy to manage heart rate and reduce myocardial oxygen demand. The ongoing assessment and integration of new diagnostic information underscored the need for a dynamic and coordinated approach to care, as the patient remained at risk for further complications. Clinicians were tasked with balancing the need for adequate perfusion and oxygenation while preventing exacerbation of heart failure, guiding the next steps in the patient's treatment regimen.

Section 5

The next morning, during the routine assessment, the patient's clinical status exhibited subtle yet significant changes. His vital signs revealed a blood pressure of 100/65 mmHg, down from 115/75 mmHg the previous evening, with a heart rate of 95 beats per minute, slightly elevated from its baseline. The patient reported mild shortness of breath and an increasing sense of fatigue, which were new developments. Auscultation of the lungs indicated faint crackles at the bases, suggesting potential pulmonary congestion. The nursing team noted mild peripheral edema in the lower extremities, raising concerns about fluid retention and the progression toward heart failure.

In light of these findings, the interdisciplinary team decided to implement further diagnostic testing to evaluate the patient's volume status and cardiac function. A BNP (B-type natriuretic peptide) test was ordered, returning a result of 550 pg/mL, indicative of fluid overload and cardiac strain. Additionally, a repeat chest X-ray was performed, revealing mild pulmonary vascular congestion without overt pulmonary edema. These results confirmed the suspicion of early heart failure, likely exacerbated by the recent myocardial infarction and reduced ejection fraction.

In response, the clinical team adjusted the patient's diuretic therapy, increasing the dose of furosemide to promote diuresis and alleviate fluid overload. Concurrently, they initiated a low sodium diet to reduce further fluid retention. The cardiology consultation recommended the cautious initiation of low-dose beta-blocker therapy to manage heart rate and decrease myocardial oxygen demand, while closely monitoring the patient's hemodynamic status. The team emphasized the importance of frequent reassessments and ongoing communication to adapt the treatment plan as needed, aiming to stabilize the patient and prevent further deterioration.